Eight Capital Ptnrs. - Investment in Epsion Capital Limited
RNS Number : 3505S
Eight Capital Partners PLC
08 March 2019

8 March 2019

Eight Capital Partners Plc

("Eight Capital" or the "Company")

Investment in Epsion Capital Limited

Eight Capital, the investing company focussed on financial services, telecoms, media and technology, is pleased to announce it has subscribed for new ordinary shares in Epsion Capital Limited ("Epsion"), a boutique financial advisory and investment firm based in London, equating to 70 per cent. of the share capital of Epsion.  The consideration for the new shares is £3,500.

The Company believes that there are significant opportunities to create synergies with Epsion by providing advisory services to its investee companies. Epsion is currently engaged in two corporate finance transactions and has a pipeline of future mandates from which it expects to derive a growing revenue stream. 

Related-party transaction

John Treacy, a Non-executive Director of Eight Capital, is also the sole director and shareholder of Epsion, therefore, the investment in Epsion constitutes a related-party transaction pursuant to the NEX Exchange Growth Market Rules for Issuers.

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/201.

The directors of the Company accept responsibility for the contents of this announcement.

- ENDS -

For further information, please contact:        

Eight Capital Partners Plc:                                         +44 (0) 20 7469 0930     info@eight.capital           

Dominic White  

NEX Exchange Corporate Adviser:  

Peterhouse Capital Limited                                        +44 (0)20 7469 0930

Guy Miller and Fungai Ndoro

Financial PR:

Abigail Stuart-Menteth                                               +44 (0)207 812 0645    

Email: eightcapitalplc@damsonpr.com

This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.